
CPHI Korea 2026
08/2026 – 08/2026
A CDMO specializing in hybrid formulations that combine natural products with synthetic drugs, Benaturebiolab uses proprietary HME-DDS technology to enhance bioavailability and enable precise control over drug release profiles for pharmaceuticals, functional foods and cosmeceuticals, providing development support from formulation through production.

댓글이 없습니다.
평가 & 댓글 남기기